Attached files

file filename
EX-10.8 - EX-10.8 - Atea Pharmaceuticals, Inc.d913778dex108.htm
EX-4.1 - EX-4.1 - Atea Pharmaceuticals, Inc.d913778dex41.htm
S-1/A - AMENDMENT 1 TO FORM S-1 - Atea Pharmaceuticals, Inc.d913778ds1a.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Atea Pharmaceuticals, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Boston, Massachusetts

October 22, 2020